Skip to main content
Livermore
Livermore
ZHEN

First Trust Advisors LP

SEC CIK
0001125816
Latest filing
Aug 11, 2026

BCRX holding history

Biocryst Pharmaceuticals Inc in every 13F filed by First Trust Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCRX overviewAll 13F holders of BCRXFull Q2 2026 holdings

Shares (Q2 2026)
1,120,469
Value
$11.2M
% of portfolio
<0.1%
Quarters held
19
Since Q2 2021
Holdings of BCRX by First Trust Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,120,469$11.2M<0.1%+319,569+39.9%AddedHolders
Q1 2026800,900$7.62M<0.1%+425,939+113.6%AddedHolders
Q4 2025374,961$2.92M<0.1%−360,026−49.0%ReducedHolders
Q3 2025734,987$5.58M<0.1%+7,517+1.0%AddedHolders
Q2 2025727,470$6.52M<0.1%+241,988+49.8%AddedHolders
Q1 2025485,482$3.64M<0.1%−79,733−14.1%ReducedHolders
Q4 2024565,215$4.25M<0.1%−28,251−4.8%ReducedHolders
Q3 2024593,466$4.51M<0.1%+593,466NewHolders
Q2 20240$00.0%−141,387−100.0%Sold outHolders
Q1 2024141,387$718.2K<0.1%−19,337−12.0%ReducedHolders
Q4 2023160,724$962.7K<0.1%+160,724NewHolders
Q3 20230$00.0%−176,763−100.0%Sold outHolders
Q2 2023176,763$1.24M<0.1%+13,600+8.3%AddedHolders
Q1 2023163,163$1.36M<0.1%−40,471−19.9%ReducedHolders
Q4 2022203,634$2.34M<0.1%+78,566+62.8%AddedHolders
Q3 2022125,068$1.58M<0.1%−159,783−56.1%ReducedHolders
Q2 2022284,851$3.01M<0.1%+109,834+62.8%AddedHolders
Q1 2022175,017$2.85M<0.1%−130,734−42.8%ReducedHolders
Q4 2021305,751$4.24M<0.1%+59,305+24.1%AddedHolders
Q3 2021246,446$3.54M<0.1%−100,387−28.9%ReducedHolders
Q2 2021346,833$5.48M<0.1%+346,833NewHolders